SKI Market

Indian Indices

Nifty

24,585.05 221.75
(0.91%)

Sensex

80,235.59 -368.49
( -0.46%)

Bank Nifty

55,510.75 505.85
( 0.92%)

Nifty IT

34,544.65 146.15
( 0.42%)

Global Indices

Nasdaq

44,012.84 -183.78
(-0.42%)

Dow Jones

6,397.00 13.45
(-0.21%)

Hang Seng

42,778.56 958.08
(2.29%)

Nikkei 225

9,129.71 33.98
(0.37%)

Forex

USD-INR

87.65 0.09
(0.10%)

EUR-INR

102.02 -0.05
(-0.04%)

GBP-INR

117.85 0.54
(0.46%)

JPY-INR

0.59 0.00
(-0.24%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Kilitch Drugs (India) Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524500

INE729D01010

173.2573795

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

KILITCH

24.97

777.89

EPS(TTM)

Face Value()

Div & Yield %

17.82

Particulars(INCOME)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)
Sales Turnover	131.60	117.78	105.16	70.02	60.77	96.42
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	131.60	117.78	105.16	70.02	60.77	96.42
Other Income	6.19	4.60	4.56	4.19	5.71	4.52
Stock Adjustments	0.12	-0.23	0.05	-1.09	0.73	0.18
Total Income	137.91	122.15	109.77	73.12	67.21	101.12
EXPENDITURE :
Raw Materials	66.33	58.27	60.29	37.97	36.49	53.16
Power & Fuel Cost	2.36	2.15	2.00	1.57	1.62	1.41
Employee Cost	7.91	7.47	6.15	5.22	5.65	5.23
Other Manufacturing Expenses	4.69	5.37	5.91	5.48	4.62	3.80
Selling & Administrative Expenses	26.71	23.08	16.48	11.11	11.12	12.13
Miscellaneous Expenses	3.29	3.88	3.25	2.25	0.40	4.00
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	111.29	100.22	94.08	63.59	59.91	79.74
Operating Profit	26.62	21.94	15.69	9.53	7.31	21.38
Interest	2.02	1.15	0.80	0.88	0.93	0.65
Gross Profit	24.60	20.79	14.89	8.65	6.38	20.73
Depreciation	1.24	1.34	0.96	1.14	1.15	1.20
Profit Before Tax	23.36	19.45	13.93	7.51	5.23	19.53
Tax	6.37	4.20	3.63	1.67	0.70	4.24
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.59	-0.47	-0.23	-0.31	0.07	0.52
Reported Net Profit	17.57	15.72	10.53	6.16	4.46	14.77
Extraordinary Items	0.86	0.77	1.00	0.94	1.55	1.72
Adjusted Net Profit	16.71	14.95	9.53	5.22	2.91	13.05
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	113.96	98.24	87.71	81.56	78.03	64.19
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.93	0.93
P & L Balance carried down	131.53	113.96	98.24	87.71	81.56	78.03
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	5.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.50
Earnings Per Share-Unit Curr	10.93	10.09	6.76	3.97	2.89	9.62
Earnings Per Share(Adj)-Unit Curr	10.70	9.87	6.62	3.89	2.83	9.41
Book Value-Unit Curr	138.61	122.53	112.65	105.16	98.25	98.39
Book Value(Adj)-Unit Curr	135.64	119.91	110.24	102.92	96.15	96.28

24,585.05 221.75 (0.91%)

80,235.59 -368.49 ( -0.46%)

55,510.75 505.85 ( 0.92%)

34,544.65 146.15 ( 0.42%)

44,012.84 -183.78 (-0.42%)

6,397.00 13.45 (-0.21%)

42,778.56 958.08 (2.29%)

9,129.71 33.98 (0.37%)

87.65 0.09 (0.10%)

102.02 -0.05 (-0.04%)

117.85 0.54 (0.46%)

0.59 0.00 (-0.24%)